Case Report of Non-Small Cell Lung Cancer with STRN-ALK Translocation: A Nonresponder to Alectinib

被引：30
|
作者：
Nakanishi, Yoko [1 ]
Masuda, Shinobu [1 ]
Iida, Yuko [2 ]
Takahashi, Noriaki [2 ]
Hashimoto, Shu [2 ]
机构：
[1] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Oncol Pathol, Tokyo, Japan
[2] Nihon Univ, Sch Med, Dept Internal Med, Div Resp Med, 30-1 Ohyaguchi Kamimachi, Tokyo 1738610, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 12期
关键词：
POTENTIAL THERAPEUTIC TARGET; FUSION;
D O I：
10.1016/j.jtho.2017.08.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E202 / E204
页数：4
相关论文
共 50 条
  • [1] Primary resistance to alectinib in a patient with STRN-ALK-positive non-small cell lung cancer: A case report
    Sun, Kunyan
    Nie, Ligong
    Nong, Lin
    Cheng, Yuan
    THORACIC CANCER, 2021, 12 (12) : 1927 - 1930
  • [2] Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report
    Zhu, Lucheng
    Ma, Shenglin
    Xia, Bing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] A Lung Adenocarcinoma with a STRN-ALK Rearrangement Was Poorly Responsive to Alectinib Treatment
    Iida, Y.
    Nakanishi, Y.
    Takahashi, N.
    Nishimaki, H.
    Nishizawa, T.
    Nakagawa, Y.
    Shimizu, T.
    Gon, Y.
    Masuda, S.
    Hashimoto, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1953 - S1953
  • [4] STRN-ALK Fusion-Positive Case of Breast Cancer With Response to Alectinib
    Kelly, Andrew D.
    Wiklund, Tom
    Kononen, Juha
    Creeden, James
    JCO PRECISION ONCOLOGY, 2021, 5 : 1281 - 1284
  • [5] Case Report: A rare case of non-small cell lung cancer with STRN-ALK fusion in a patient in very poor condition treated with first-line ensartinib
    Song, Guo-qiang
    Li, Yi-zhong
    Kong, Weiliang
    Hu, Guo-qiang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] STRN-ALK Fusion in Lung Adenocarcinoma with Excellent Response Upon Alectinib Treatment: A Case Report and Literature Review
    Su, Cuiyun
    Jiang, Ya
    Jiang, Wei
    Wang, Huilin
    Liu, Sisi
    Shao, Yang
    Zhao, Wenhua
    Ning, Ruiling
    Yu, Qitao
    ONCOTARGETS AND THERAPY, 2020, 13 : 12515 - 12519
  • [7] Alectinib/crizotinibDevelopment of drug resistance in ALK-positive non-small cell lung cancer: case report
    Reactions Weekly, 2020, 1829 (1) : 23 - 23
  • [8] Alectinib/crizotinibAcquired resistance to alectinib and crizotinib in non-small cell lung cancer: case report
    Reactions Weekly, 2018, 1707 (1) : 23 - 23
  • [9] Case Report: Identification of Two Rare Fusions, PDK1-ALK and STRN-ALK, That Coexist in a Lung Adenocarcinoma Patient and the Response to Alectinib
    Zeng, Hao
    Li, Yalun
    Wang, Ye
    Huang, Meijuan
    Zhang, Yan
    Tian, Panwen
    Li, Weimin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Alectinib/crizotinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2016, 1616 (1) : 15 - 15
12345